Steward Partners Investment Advisory’s Apyx Medical APYX Stock Holding History

Steward Partners Investment Advisory’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,350	Closed	-$74K	–	3233
2022 Q1	$74K	Hold	11,350	–	–	﹤0.01%	1721
2021 Q4	$146K	Hold	11,350	–	–	﹤0.01%	1435
2021 Q3	$157K	Hold	11,350	–	–	﹤0.01%	1368
2021 Q2	$117K	Hold	11,350	–	–	﹤0.01%	2020
2021 Q1	$110K	Hold	11,350	–	–	﹤0.01%	1573
2020 Q4	$82K	Hold	11,350	–	–	﹤0.01%	1444
2020 Q3	$53K	Hold	11,350	–	–	﹤0.01%	1474
2020 Q2	$63K	Hold	11,350	–	–	﹤0.01%	1315
2020 Q1	$40K	Hold	11,350	–	–	﹤0.01%	1349
2019 Q4	$96K	Hold	11,350	–	–	﹤0.01%	1150
2019 Q3	$76K	Hold	11,350	–	–	﹤0.01%	1192
2019 Q2	$76K	Buy	11,350 +500	+5%	+$2.72K	﹤0.01%	1168
2019 Q1	$68K	Sell	10,850 -750	-6%	-$5.8K	﹤0.01%	782
2018 Q4	$75K	Hold	11,600	–	–	﹤0.01%	759
2018 Q3	$82K	Buy	11,600 +4,825	+71%	+$26.8K	﹤0.01%	992
2018 Q2	$29K	Sell	6,775 -1,000	-13%	-$3.69K	﹤0.01%	1305
2018 Q1	$23K	Sell	7,775 -1,250	-14%	-$3.22K	﹤0.01%	1274
2017 Q4	$23K	Hold	9,025	–	–	﹤0.01%	1063
2017 Q3	$30K	Buy	9,025 +5,910	+190%	+$15.3K	﹤0.01%	824
2017 Q2	$7K	Buy	+3,115	New	+$7.66K	﹤0.01%	1130

Other funds holding APYX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Invenire Partners Ridgefield, Connecticut $65.4M AUM 18.1% 1-Year Est. Return

Steward Partners Investment Advisory's APYX Position: Q2 2022 in Review

Steward Partners Investment Advisory sold out of Apyx Medical (APYX) in Q2 2022, closing a stake of 11,350 shares — an estimated $74K sold.

Steward Partners Investment Advisory first reported a position in APYX in Q2 2017 and held it in 20 quarters. The position peaked at $157K in Q3 2021. 63 funds tracked by Wall St. Rank hold APYX as of Q2 2022.

Steward Partners Investment Advisory reported no remaining Apyx Medical position as of Q2 2022 after selling out during the quarter.
Steward Partners Investment Advisory sold 11,350 Apyx Medical shares in Q2 2022, an estimated $74K.
Steward Partners Investment Advisory first reported a position in Apyx Medical in Q2 2017 and held it in 20 quarters.
Steward Partners Investment Advisory's Apyx Medical position peaked at $157K in Q3 2021.
63 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2022.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2022, filed 4 Aug 2022.